Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19.0Revenue (TTM) $M0.9Net Margin (%)-7,103.7Altman Z-Score-23.0
Enterprise Value $M16.7EPS (TTM) $-1.7Operating Margin %-9,277.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-7.7Pre-tax Margin (%)-7,103.7Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales15.35-y EBITDA Growth Rate %-56.0Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-93.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M41.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARGS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARGS is held by these investors:



ARGS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pharmstandard International S.10% Owner 2016-10-07Buy31,704$4.73-90.27view
Pharmstandard International S.10% Owner 2016-09-29Buy43,618$4.56-89.91view
Pharmstandard International S.10% Owner 2016-09-20Buy46,839$4.77-90.36view
Pharmstandard International S.10% Owner 2016-09-16Buy52,512$4.77-90.36view
Pharmstandard International S.10% Owner 2016-09-01Buy16,977$4.78-90.38view
Pharmstandard International S.10% Owner 2016-08-24Buy67,371$4.52-89.82view
Pharmstandard International S.10% Owner 2016-08-24Buy55,224$4.57-89.93view
Pharmstandard International S.10% Owner 2016-08-22Buy75,474$4.24-89.15view
Winterbottom JoanChief Human Resources Officer 2015-12-16Buy250$1.83-74.86view
Petrov Andrei VladimirovichDirector 2015-12-16Buy5,000$1.8-74.44view

Press Releases about ARGS :

Quarterly/Annual Reports about ARGS:

    News about ARGS:

    Articles On GuruFocus.com
    Argos Provides Update on its ADAPT Trial Following Meeting with FDA May 10 2017 
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,0 May 09 2017 
    Argos Reports Interim Results of the ADAPT Trial and Provides Perspective on Decision to Continue th Apr 18 2017 
    The Klein Law Firm Announces a Class Action Has Been Filed on Behalf of Argos Therapeutics, Inc. Sha Apr 13 2017 
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Inve Apr 06 2017 
    IMPORTANT ARGOS THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announc Mar 22 2017 
    ARGS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Clas Mar 20 2017 
    SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Mar 18 2017 
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,0 Mar 16 2017 
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed in U.S. District Court t Mar 15 2017 

    More From Other Websites
    Argos CEO talks company plans to move forward May 11 2017
    ARGS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a... May 10 2017
    Argos Provides Update on its ADAPT Trial Following Meeting with FDA May 10 2017
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of... May 09 2017
    Argos Therapeutics faces threat of delisting May 05 2017
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Complaint Filed in U.S. District... Apr 25 2017
    Robbins Arroyo LLP Reminds Investors of Lead Plaintiff Deadline in Argos Therapeutics, Inc. (ARGS)... Apr 24 2017
    The Klein Law Firm Announces the Commencement of a Class Action Filed on Behalf of Argos... Apr 21 2017
    DEADLINE ALERT: Brower Piven Alerts Shareholders of Approaching Deadline in Class Action Lawsuit and... Apr 20 2017
    Argos Reports Interim Results of the ADAPT Trial and Provides Perspective on Decision to Continue... Apr 18 2017
    Chief medical officer departs troubled Argos Apr 14 2017
    The Klein Law Firm Announces a Class Action Has Been Filed on Behalf of Argos Therapeutics, Inc.... Apr 13 2017
    ETFs with exposure to Argos Therapeutics, Inc. : April 7, 2017 Apr 07 2017
    The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar... Apr 07 2017
    EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders it Has Filed in U.S. District Court to... Apr 06 2017
    3 of the Best & Worst Performing Drug Stocks of Q1 Apr 06 2017
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Apr 06 2017
    ARGS INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving... Apr 03 2017
    INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed in U.S. District Court to... Mar 28 2017
    INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From... Mar 27 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)